Xenetic Biosciences Inc (XBIO)
3.96
-0.31
(-7.26%)
USD |
NASDAQ |
May 06, 16:00
3.95
-0.01
(-0.25%)
After-Hours: 20:00
Xenetic Biosciences Cash from Operations (TTM): -4.114M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.114M |
September 30, 2023 | -4.072M |
June 30, 2023 | -4.202M |
March 31, 2023 | -3.662M |
December 31, 2022 | -4.647M |
September 30, 2022 | -5.355M |
June 30, 2022 | -5.309M |
March 31, 2022 | -5.307M |
December 31, 2021 | -4.738M |
September 30, 2021 | -4.233M |
June 30, 2021 | -4.212M |
March 31, 2021 | -4.786M |
December 31, 2020 | -4.267M |
September 30, 2020 | -4.991M |
June 30, 2020 | -6.395M |
March 31, 2020 | -6.146M |
December 31, 2019 | -6.399M |
September 30, 2019 | -5.762M |
June 30, 2019 | -5.014M |
March 31, 2019 | -6.052M |
December 31, 2018 | -6.464M |
September 30, 2018 | -0.5848M |
June 30, 2018 | -0.5538M |
Date | Value |
---|---|
March 31, 2018 | -0.4534M |
December 31, 2017 | 1.494M |
September 30, 2017 | -7.968M |
June 30, 2017 | -7.360M |
March 31, 2017 | -6.731M |
December 31, 2016 | -8.787M |
September 30, 2016 | -5.279M |
June 30, 2016 | -6.205M |
March 31, 2016 | -5.039M |
December 31, 2015 | -5.301M |
September 30, 2015 | -6.850M |
June 30, 2015 | -7.577M |
March 31, 2015 | -10.60M |
December 31, 2014 | -12.68M |
September 30, 2014 | -10.19M |
June 30, 2014 | -7.258M |
March 31, 2014 | -4.030M |
November 30, 2013 | 0.1075M |
August 31, 2013 | 0.2806M |
May 31, 2013 | 0.0291M |
February 28, 2013 | -0.0014M |
November 30, 2012 | -0.0112M |
August 31, 2012 | -0.013M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-6.399M
Minimum
Dec 2019
-3.662M
Maximum
Mar 2023
-4.927M
Average
-4.786M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -9.515M |
Asensus Surgical Inc | -63.63M |
Myomo Inc | -6.173M |